Recurrent community-acquired pneumococcal meningitis in adults with and without identified predisposing factors

Maria Cecilia Cergole-Novella1, Elaine Monteiro Matsuda2, Mariana Brena de Souza1

  • 1Adolfo Lutz Institute, Santo André Regional Center, Avenida Ramiro Colleoni, 240 - Vila Dora, Santo André, SP, 09040-160, Brazil.

Insights

Recurrent bacterial meningitis, primarily caused by Streptococcus pneumoniae, affects individuals even without predisposing factors. Molecular tools aid in tracking these rare but serious infections, highlighting the need for pneumococcal vaccination.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Molecular Diagnostics

Background:

  • Bacterial meningitis remains a significant public health issue with high morbidity and mortality.
  • Recurrent meningitis, though rare, can be triggered by predisposing factors.
  • Understanding the epidemiology of recurrent meningitis is crucial for effective public health strategies.

Purpose of the Study:

  • To determine the clinical characteristics of recurrent community-acquired meningitis.
  • To analyze the molecular epidemiology of pathogens causing recurrent meningitis, with or without predisposing factors.
  • To evaluate the utility of molecular tools in diagnosing and surveilling meningitis pathogens.

Main Methods:

  • Retrospective study of a laboratory database from 2010 to 2020.
  • Molecular analysis of cerebrospinal fluid samples to identify pathogens, particularly in cases with no isolated strains.
  • Analysis of clinical data including patient age and predisposing factors.

Main Results:

  • Out of 1,779 meningitis cases, 16 were recurrent (0.9%) in seven patients, predominantly caused by Streptococcus pneumoniae.
  • The mean age of patients with recurrent meningitis was 20 years; three had predisposing factors.
  • Identified pneumococcal serotypes were often non-vaccine-covered and antibiotic-susceptible.

Conclusions:

  • Molecular tools are valuable for epidemiological surveillance in routine diagnostics.
  • Streptococcus pneumoniae is the leading cause of recurrent community-acquired meningitis, even without predisposing factors.
  • Pneumococcal vaccination may be warranted for individuals not typically considered high-risk.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
236
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
209
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
269
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
145
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K